| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...749254T |
| P356 | DOI | 10.1371/JOURNAL.PONE.0049254 |
| P932 | PMC publication ID | 3493538 |
| P698 | PubMed publication ID | 23145135 |
| P5875 | ResearchGate publication ID | 233397264 |
| P50 | author | Kiattawee Choowongkomon | Q56881876 |
| Wanpen Chaicumpa | Q60976993 | ||
| P2093 | author name string | Potjanee Srimanote | |
| Jeeraphong Thanongsaksrikul | |||
| Santi Maneewatch | |||
| Kunan Bangphoomi | |||
| Kanyarat Thueng-in | |||
| Ornnuthchar Poungpair | |||
| P2860 | cites work | Prospects for personalizing antiviral therapy for hepatitis C virus with pharmacogenetics | Q42731526 |
| Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels | Q43000433 | ||
| A nonisotopic assay method for hepatitis C virus NS5B polymerase | Q43036582 | ||
| Modulation of hepatitis C virus RNA-dependent RNA polymerase activity by structure-based site-directed mutagenesis | Q44081160 | ||
| 'Camelising' human antibody fragments: NMR studies on VH domains. | Q54639929 | ||
| Covalent immobilization of DNA onto polystyrene microwells: The molecules are only bound at the 5′ end | Q67855297 | ||
| Proteome and immunome of the venom of the Thai cobra, Naja kaouthia | Q80016957 | ||
| Evolutionary connection between the catalytic subunits of DNA-dependent RNA polymerases and eukaryotic RNA-dependent RNA polymerases and the origin of RNA polymerases | Q21256431 | ||
| Properties, production, and applications of camelid single-domain antibody fragments | Q24676749 | ||
| PROCHECK: a program to check the stereochemical quality of protein structures | Q26778411 | ||
| De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase | Q27469633 | ||
| Template requirements for RNA synthesis by a recombinant hepatitis C virus RNA-dependent RNA polymerase | Q27469758 | ||
| Robust hepatitis C virus infection in vitro | Q27470013 | ||
| Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity | Q27480890 | ||
| Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus | Q27486092 | ||
| Development of Intergenotypic Chimeric Replicons To Determine the Broad-Spectrum Antiviral Activities of Hepatitis C Virus Polymerase Inhibitors | Q27487022 | ||
| Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site | Q27619818 | ||
| Production of infectious hepatitis C virus in tissue culture from a cloned viral genome | Q27860899 | ||
| Naturally occurring antibodies devoid of light chains | Q28269589 | ||
| Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin | Q33402028 | ||
| A V H H that neutralizes the zinc metalloproteinase activity of botulinum neurotoxin type A | Q33525766 | ||
| Interactions of protein antigens with antibodies | Q33594252 | ||
| Antiviral stilbene 1,2-diamines prevent initiation of hepatitis C virus RNA replication at the outset of infection | Q33853582 | ||
| Botulinum neurotoxins and botulism: a novel therapeutic approach | Q34070659 | ||
| Humanized-single domain antibodies (VH/VHH) that bound specifically to Naja kaouthia phospholipase A2 and neutralized the enzymatic activity | Q34360982 | ||
| Crystal structures of the RNA-dependent RNA polymerase genotype 2a of hepatitis C virus reveal two conformations and suggest mechanisms of inhibition by non-nucleoside inhibitors | Q34399887 | ||
| Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains | Q34662422 | ||
| Optimal therapy of hepatitis C. | Q34984079 | ||
| Characterization of resistance to the nonnucleoside NS5B inhibitor filibuvir in hepatitis C virus-infected patients | Q35806182 | ||
| Nomenclature and functions of RNA-directed RNA polymerases | Q36394550 | ||
| The essential role of C-terminal residues in regulating the activity of hepatitis C virus RNA-dependent RNA polymerase. | Q38361069 | ||
| A human single chain transbody specific to matrix protein (M1) interferes with the replication of influenza A virus | Q39691105 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e49254 | |
| P577 | publication date | 2012-11-08 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Cell penetrable humanized-VH/V(H)H that inhibit RNA dependent RNA polymerase (NS5B) of HCV. | |
| P478 | volume | 7 |
| Q59350366 | A Nanobody Targeting Viral Non-Structural Protein 9 Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication |
| Q28386635 | A peptide mimic blocks the cross-reaction of anti-DNA antibodies with glomerular antigens |
| Q35829537 | An intracellularly expressed Nsp9-specific nanobody in MARC-145 cells inhibits porcine reproductive and respiratory syndrome virus replication |
| Q35542237 | Cargo-delivery platforms for targeted delivery of inhibitor cargos against botulism |
| Q35014925 | Cell penetrable human scFv specific to middle domain of matrix protein-1 protects mice from lethal influenza |
| Q55554478 | Evolution of Therapeutic Antibodies, Influenza Virus Biology, Influenza, and Influenza Immunotherapy. |
| Q37208481 | Human Transbodies to HCV NS3/4A Protease Inhibit Viral Replication and Restore Host Innate Immunity |
| Q34721639 | Human monoclonal ScFv that bind to different functional domains of M2 and inhibit H5N1 influenza virus replication |
| Q44533500 | Human single chain-transbodies that bound to domain-I of non-structural protein 5A (NS5A) of hepatitis C virus |
| Q35544421 | Humanized-VHH transbodies that inhibit HCV protease and replication |
| Q35526955 | Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase |
| Q38654845 | Nanobody Technology: A Versatile Toolkit for Microscopic Imaging, Protein-Protein Interaction Analysis, and Protein Function Exploration. |
| Q36300378 | Single domain antibodies for the knockdown of cytosolic and nuclear proteins |
| Q47554821 | Single-Domain Antibodies As Therapeutics against Human Viral Diseases |
| Q91610417 | Single-Domain Antibodies Represent Novel Alternatives to Monoclonal Antibodies as Targeting Agents against the Human Papillomavirus 16 E6 Protein |
| Q90211736 | Single-Domain Antibodies and Their Formatting to Combat Viral Infections |
| Q33831589 | Specific B-cell Epitope of Per a 1: A Major Allergen of American Cockroach (Periplaneta americana) and Anatomical Localization |
| Q35979261 | Structural Characterization of Humanized Nanobodies with Neutralizing Activity against the Bordetella pertussis CyaA-Hemolysin: Implications for a Potential Epitope of Toxin-Protective Antigen |
| Q55045321 | Targeting G protein-coupled receptor signaling at the G protein level with a selective nanobody inhibitor. |
| Q40255481 | Transbody against virus core protein potently inhibits hepadnavirus replication in vivo: evidence from a duck model of hepatitis B virus |
| Q50743140 | Variable Heavy Chain Domain Derived from a Cell-Penetrating Anti-DNA Monoclonal Antibody for the Intracellular Delivery of Biomolecules. |
Search more.